Byzen Digital Inc
Change company Symbol lookup
Select an option...
BYZN Byzen Digital Inc
XOM Exxon Mobil Corp
EPD Enterprise Products Partners LP
STLB Sterling Business Solutions Inc
CITY Avalon Correctional Services Inc
TEVJF Teva Pharmaceutical Industries Ltd
UMBF UMB Financial Corp
OXM Oxford Industries Inc
ICON Iconix Brand Group Inc
BAC Bank of America Corp
Go

Information Technology : IT Services |
Based in China
Company profile

Byzen Digital Inc. (formerly Emergency Pest Services Inc.) is a China-based company principally engaged in the development of a complete blockchain eco-system for Crypto requirements as its main objective. Byzen Digital Inc. has already made its first two acquisitions. Telecoin is a typical Crypto-currency company and Digi Ex is a company specialized in the marketing and promoting of Crypto-currencies. The Company help take its customers on a journey towards a much wider understanding of what Crypto and Blockchain technologies really are through its products. The Company also focuses to incorporate start-ups and small and medium-sized enterprises (SMEs) from the technology sectors, including cybersecurity, data storage, cloud-tech, analytics, software and digital applications.

Price
Delayed
$0.16
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 0 shares is on pace to be much lighter than BYZN's 10-day average volume of 898,364 shares.

0

Drug Eluting Stent Market to Exhibit 6.6% CAGR by 2026; Advent of Novel Drug Eluting Stents Will Contribute Significantly to the Market Growth: Fortune Business Insights(TM)

11:33 am ET April 14, 2020 (Globe Newswire) Print

The global Drug Eluting Stent Market size is forecast to reach USD 9.58 billion by 2026, attributable to the increasing prevalence of cardiovascular diseases worldwide. A drug eluting stent is a semi-rigid device in the form of a tube that is coated with a drug that helps to prevent restenosis of an arterial blockage when released. They help to reduce restenosis cases and also limits the risk of late or early thrombosis in patients. More information on the market is provided in a recently published report by Fortune Business Insights(TM) titled, "Drug Eluting Stent Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026." As per this report, the market value was USD 5.71 billion in 2019 and will exhibit a CAGR of 6.6% between 2019 to 2026.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-eluting-stent-des-market-102612

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612

What is the Scope of the Report?

The report offers a 360-degree overview of the market and its prime growth trajectories such as drivers, restraints, challenges, and upcoming opportunities. It also discusses the market segment based on factors such as type, scaffold, drug, end-user, and regions. It also provides market figures and CAGRs of the leading segments with its attributed reasons. Additionally, the report throws light on current drug eluting stent market trends, key industry developments, and other interesting insights. Competitive landscape, list of players operating in the market and the strategies adopted by them to earn the leading position in the market are also listed in the report. For more information on the report, log on to the company website.

Market Drivers

Improving Healthcare Infrastructure in Developing Nations will Propel Growth

The increasing cases of cardiovascular diseases worldwide is a significant factor in boosting the global market for drug eluting stents. Besides this, government-supported reimbursement policies and rise in expenditure on research and development of better stents are also aiding in the expansion of the market. This, coupled with the FDA approvals and CE marks received for many stents, is expected to promote the drug eluting stent market growth in the forecast period.

On the other side, the market may face challenges in terms of product recalls. Nevertheless, the introduction of technologically advanced and novel therapeutics is likely to create lucrative growth opportunities for the market in the coming years.

Quick Buy - Drug Eluting Stent Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102612

Regional Segmentation:

Rising Prevalence of Cardiovascular Diseases Will Help Asia Pacific Witness Significant Growth

Currently, North America is holding the significant share drug eluting stent market share owing to the increasing prevalence of cardiovascular diseases and the supported reimbursement policies supported by governments in the region. In 2018, this region generated a revenue of USD 1.76 billion. Additionally, the increasing trend of biodegradable polymer-based drug eluting scaffolds may further help this region continue dominance in the forecast period as well. On the other side, the market in Europe will emerge as the fastest-growing region owing to the rise in the number of third-generation DES with the CE mark and the rising popularity of polymer technology for the production of stents. Furthermore, the increasing cases of cardiovascular diseases and the improving medical infrastructure and medical facilities will help Asia Pacific witness significant growth in the coming years.

Competitive Landscape:

Boston, Abbott, and Medtronic Collectively Holding a Dominant Share in the Consolidated Market

The global drug eluting stent market is consolidated in nature with the presence of both small, medium, and large players. Companies are aiming to develop a DES of various sizes to target multiple indications. Currently, players such as Boston Scientific Corporation, Medtronic, and Abbott are holding more than 50% of the DES market share. All players are focusing on getting FDA approvals and CE marks from authorities for gaining a competitive edge in the market and earn more drug eluting stents market revenue in the forthcoming years.

List of Significant Drug Eluting Stent Market Manufacturers are as follows:

-- Boston Scientific Corporation

-- Abbott

-- Medtronic

-- Biotronik

-- Terumo Corporation

-- MicroPort Scientific Corporation

-- Sahajanand Medical Technologies

-- Others

Major Industry Developments of the Drug Eluting Stents Market are the following:

February 2018 - The U.S. FDA approved the launch of the smallest DES into the market called Resolute Onyx 2.0 mm to help patients with coronary artery diseases (CAD).

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/drug-eluting-stent-des-market-102612

Detailed Table of Content:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- Prevalence of Cardiovascular Diseases, By Key Regions/ Key Countries, 2018

        -- Prevalence of Cardiovascular Diseases, By Key Regions/ Key Countries, 2018

        -- New Product Launches, By Key Market Players

        -- Key Industry Developments, Such as Mergers & Acquisitions

        -- Pricing Analysis, By Key Brands, Key Players/ Key Regions

        -- Global Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2015-2026

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Type

            -- Coronary Stenting

            -- Coronary Stenting

            -- Peripheral Stenting

            -- Market Analysis, Insights and Forecast - By Scaffold

              -- Cobalt-Chromium

              -- Cobalt-Chromium

              -- Platinum-Chromium

              -- Nitinol

              -- Others

              -- Market Analysis, Insights and Forecast - By Drug

                -- Sirolimus

                -- Sirolimus

                -- Paclitaxel

                -- Zotarolimus

                -- Everolimus

                -- Others

                -- Market Analysis, Insights and Forecast - By End User

                  -- Hospitals

                  -- Hospitals

                  -- Specialty Clinics

                  -- Market Analysis, Insights and Forecast - By Region

                    -- North America

                    -- North America

                    -- Europe

                    -- Asia Pacific

                    -- Latin America

                    -- Middle East & Africa

                    TOC Continued....!

                    Request for Customization https://www.fortunebusinessinsights.com/enquiry/customization/drug-eluting-stent-des-market-102612

                    Have a Look at Related Reports:

                    Cardiovascular Stents Market Size, Share and Global Trend By Product Type (Coronary Stenting, Peripheral Stenting), Stent Type (Drug Eluting Stents (DES), Bioresorbable Stents, Bare Metal Stents & Others), Disease Indication (Venous Disease, Arterial Disease), End User and Geography Forecast by 2025

                    Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease, Arrhythmia, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026

                    Cardiovascular Devices Market Size, Share and Industry Analysis, By Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2019-2026

                    Coronary Stents Market Size, Share and Global Trend By Deployment (Self and Balloon-expandable), Stent Type (Drug Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Catheterization Labs) and Geography Forecast till 2025

                    About Us:

                    Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                    Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                    At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                    Contact Us:

                    Fortune Business Insights(TM) Pvt. Ltd.

                    308, Supreme Headquarters,

                    Survey No. 36, Baner,

                    Pune-Bangalore Highway,

                    Pune - 411045, Maharashtra, India.

                    Phone:

                    US :+1 424 253 0390

                    UK : +44 2071 939123

                    APAC : +91 744 740 1245

                    Email: sales@fortunebusinessinsights.com

                    Fortune Business Insights(TM)

                    LinkedIn | Twitter | Blogs

                    Press Release: https://www.fortunebusinessinsights.com/press-release/drug-eluting-stent-des-market-9749

                    https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.